教育,生活方式风险因素,治疗选择和多发性硬化症的进展
Jie Guo1, Tomas Olsson2, Jan Hillert2
1Department of Nutrition and Health, China Agricultural University, Beijing, China.
JAMA network open
|July 11, 2025
概括
教育水平没有独立预测多发性硬化症 (MS) 的进展. 生活方式和治疗因素解释了教育和MS残疾恶化之间观察到的大部分关联.
科学领域:
- 神经学 神经学
- 流行病学 流行病学
- 健康的社会经济决定因素
背景情况:
- 社会经济因素,如教育程度,可能会影响多发性硬化症 (MS) 的进展,但这种关系尚未完全理解.
- 研究教育的直接影响与生活方式和治疗的混对个性化MS护理至关重要.
研究的目的:
- 检查教育水平与残疾恶化,认知功能和MS患者的生活质量之间的关联.
- 确定生活方式因素和治疗选择是否调解了教育和MS结果之间的关系.
主要方法:
- 瑞典一项以人口为基础的队列研究分析了1995年以后诊断的3695名复发性MS患者的数据.
- 从诊断到2022年4月的随访数据被使用,教育水平分为学前,中学或中学后.
- 考克斯比例危险回归和调解分析被用来评估关联和调解效应.
主要成果:
- 较低的教育水平与更高的发病年龄,更严重的基线残疾和接受二线治疗的可能性降低有关.
- 在调整了生活方式和治疗后,低教育和更快的残疾进展之间的关联不再显著.
- 在教育水平和生活质量或认知功能的变化之间没有发现显著的关联.
结论:
- 根据教育水平,MS残疾恶化的差异似乎主要是由生活方式和治疗因素解释的.
- 教育水平本身可能不是MS进展的独立预测因素.
- 这些发现强调了在MS管理中考虑社会经济和可修改因素的重要性.
相关概念视频
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Atherosclerosis IV: Nursing Management
50
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
50
Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
Lifestyle Factors and Health
125
Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
125
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260


